Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DVS-233 SR in Adult Outpatients With Major Depressive Disorder
NCT00063206Phase 3Completed
- Sponsor
- Pfizer
- Primary completion
- May 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00063206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063206.